Categories AlphaGraphs, Earnings, Health Care
AbbVie (ABBV) Q2 2023 Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) reported second quarter 2023 earnings results today.
Worldwide net revenues were $13.8 billion, down 4.9% on a reported basis, or 4.2% on an operational basis.
Net earnings attributable to AbbVie Inc. were $2 billion, or $1.14 per share, compared to $924 million, or $0.51 per share, last year. Adjusted EPS was $2.91.
AbbVie is raising its full-year 2023 adjusted EPS guidance to $10.90-11.10 from the previous range of $10.57-10.97.
Prior performance
Most Popular
Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025
For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model
Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third
Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance
Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln
